It is generally considered that plasma is the preferred matrix for AD blood biomarkers,45 with lower concentrations of key biomarkers (e.g., p‐tau) in serum despite good assocations,46 and in the case of Aβ42, weak correlations between the matrices.46 The gene discussed is MAPT; the disease is Alzheimer disease.